IART vs ICE · rev $810.7M vs P/E 37, rev $7.28B
Integra LifeSciences Holdings (IART) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported IART revenue for 2026-06-30 was $810.7M. Net income was -$134.0K. IART currently screens at market cap $1.32B.
Latest reported ICE revenue for 2026-06-30 was $7.28B. Net income was $2.37B. Revenue was up 98.5% from 2026-03-31 to 2026-06-30. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
IART currently screens at market cap $1.32B. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the IART and ICE stock pages for the full models.
Not investment advice.